Clinical Trials Directory

Trials / Unknown

UnknownNCT04330807

Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

Chronic Kidney Disease (CKD) induces many metabolic troubles especially for the advanced CKD (stage 3b-5) patients and their prevalence and importance grow with the deterioration of the glomerular filtration rate (GFR). Among them, muscle wasting is common and multifactorial, partially explained by an imbalance between protein catabolism and synthesis. Muscular strength is also affected beyond the reduction of the lean body mass, resulting in profound fatigue. The present study seeks to quantify the prevalence of low muscular strength production (dynapenia) in a cohort of elderly patients with advanced CKD, through a maximal voluntary contraction (MVC) handgrip test compared to control data available in the literature, matched in term of age and sex. It also aims to investigate the link between the reported fatigue (subjective) and the evolution of the MVC, called critical force (fcrit) during a fatiguing task (objective fatigability).

Conditions

Interventions

TypeNameDescription
OTHERHandgrip fatigability testDynamometric and electromyographic assessment: patient is sitting on a chair, back upright, humerus vertically placed and forearm landing parallel to a support. Dominant arm is chosen for test and electrodes placement. The assessment is divided in 4 phases for a total of 30 minutes duration: Warm-up, determination of reference force settings (fast sub-maximal contractions and maximal voluntary contractions), fatigability period and rest.
OTHERQuestionnairesAssessment of subjective fatigue with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and Multidimensional Fatigue Inventory (MFI-20) questionnaires

Timeline

Start date
2020-06-22
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2020-04-02
Last updated
2022-03-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04330807. Inclusion in this directory is not an endorsement.